Royal Bank of Canada’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Buy |
1,793
+496
| +38% | +$277 | ﹤0.01% | 6488 |
|
|
2025
Q1 | $0 | Sell |
1,297
-3,225
| -71% | – | ﹤0.01% | 6471 |
|
|
2024
Q4 | $3K | Sell |
4,522
-893
| -16% | -$592 | ﹤0.01% | 6140 |
|
|
2024
Q3 | $3K | Buy |
5,415
+508
| +10% | +$281 | ﹤0.01% | 6121 |
|
|
2024
Q2 | $13K | Buy |
+4,907
| New | +$13K | ﹤0.01% | 5844 |
|
|
2024
Q1 | – | Sell |
-370
| Closed | – | – | 6635 |
|
|
2023
Q4 | $0 | Buy |
370
+208
| +128% | – | ﹤0.01% | 6661 |
|
|
2023
Q3 | $0 | Sell |
162
-197
| -55% | – | ﹤0.01% | 6661 |
|
|
2023
Q2 | $1K | Buy |
+359
| New | +$1K | ﹤0.01% | 6529 |
|
|
2022
Q4 | – | Sell |
-169
| Closed | – | – | 6833 |
|
|
2022
Q3 | $0 | Buy |
+169
| New | – | ﹤0.01% | 7019 |
|
|
2022
Q2 | – | Sell |
-60
| Closed | – | – | 6947 |
|
|
2022
Q1 | $0 | Buy |
+60
| New | – | ﹤0.01% | 7273 |
|